Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus ...

Natco Pharma Ltd is quoting at Rs 1324, up 3.15% on the day as on 12:49 IST on the NSE. The stock is up 54.09% in last one year as compared to a 7.61% gain in NIFTY and a 18.78% gain in the Nifty ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Natco Pharma Ltd has achieved a significant milestone with the approval from the US health regulator for its generic version of Everolimus tablets for oral suspension. This approval marks a key step ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

Nippon India Nifty Smallcap 250 Index Fund (G) 11.37 96,880 0.60 Nippon India Nifty Smallcap 250 Index Fund (IDCW) 11.37 96,880 0.60 Nippon India Nifty Smallcap 250 Index Fund-Dir (G) 11.37 96,880 ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 22,961.89 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...